CIBC Private Wealth Group
PTCT icon

CIBC Private Wealth Group’s PTC Therapeutics PTCT Stock Holding History

CIBC Private Wealth Group’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$191K Buy
+2,518
New +$183K ﹤0.01% 1215
2018
Q3 		– Sell
-286
Closed -$10K – 1531
2018
Q2 		$10K Buy
+286
New +$8.92K ﹤0.01% 1568

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

CIBC Private Wealth Group's PTCT Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in PTC Therapeutics (PTCT) in Q4 2025: 2,518 shares worth $191K. The stake represents ﹤0.01% of the portfolio and ranks #1215 among its holdings. This is a return to the name: CIBC Private Wealth Group previously reported a position in PTCT as recently as Q2 2018.

CIBC Private Wealth Group first reported a position in PTCT in Q2 2018 and has held it in 2 quarters since. 353 funds tracked by Wall St. Rank hold PTCT as of Q4 2025.

  • CIBC Private Wealth Group held 2,518 shares of PTC Therapeutics worth $191K as of Q4 2025.
  • PTC Therapeutics was a new CIBC Private Wealth Group position in Q4 2025.
  • PTC Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1215 holding.
  • CIBC Private Wealth Group first reported a position in PTC Therapeutics in Q2 2018 and has held it in 2 quarters since.
  • 353 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.